These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6202915)
41. [Benign prostatic hypertrophy with high levels of gamma-seminoprotein (gamma-Sm), prostate specific antigen: report of two cases]. Asakawa M; Yasumoto R; Kamizuru M; Maekawa M Hinyokika Kiyo; 1988 Dec; 34(12):2189-91. PubMed ID: 2467544 [TBL] [Abstract][Full Text] [Related]
42. Prostate-specific antigenic domain of human prostate specific antigen identified with monoclonal antibodies. Chu TM; Kawinski E; Hibi N; Croghan G; Wiley J; Killian CS; Corral D J Urol; 1989 Jan; 141(1):152-6. PubMed ID: 2462065 [TBL] [Abstract][Full Text] [Related]
43. [The nature of the antigenic restructuring of tumors of the human prostate]. Nikolaev AA Vopr Onkol; 1988; 34(9):1064-70. PubMed ID: 2460999 [TBL] [Abstract][Full Text] [Related]
44. Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice. Ford TF; Butcher DN; Masters JR; Parkinson MC Br J Urol; 1985 Feb; 57(1):50-5. PubMed ID: 2578846 [TBL] [Abstract][Full Text] [Related]
45. Prostatic specific antigen in prostate cancer. Morote J; Ruibal A Int J Biol Markers; 1987; 2(2):133. PubMed ID: 2454273 [No Abstract] [Full Text] [Related]
46. Prostate-specific antigen. Improving its ability to diagnose early prostate cancer. Oesterling JE JAMA; 1992 Apr 22-29; 267(16):2236-8. PubMed ID: 1372945 [No Abstract] [Full Text] [Related]
47. Immunologic studies of normal, benign, and malignant human prostatic tissue. Ablin RJ Cancer; 1972 Jun; 29(6):1570-4. PubMed ID: 4624168 [No Abstract] [Full Text] [Related]
48. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker. Mulders TM; Bruning PF; Bonfrer JM Eur J Surg Oncol; 1990 Feb; 16(1):37-41. PubMed ID: 1689677 [TBL] [Abstract][Full Text] [Related]
49. An evaluation of prostate specific antigen in prostatic cancer. Guinan P; Bhatti R; Ray P J Urol; 1987 Apr; 137(4):686-9. PubMed ID: 2435927 [TBL] [Abstract][Full Text] [Related]
50. [Mass screening for prostatic cancer in Hisayama town, Fukuoka]. Naito S; Kaji S; Matsumoto T; Kumazawa J; Hasuo H; Ueda K; Fujishima M Nihon Hinyokika Gakkai Zasshi; 1990 Dec; 81(12):1844-8. PubMed ID: 1705589 [TBL] [Abstract][Full Text] [Related]
52. Genomic sequence of human prostate specific antigen (PSA). Klobeck HG; Combriato G; Schulz P; Arbusow V; Fittler F Nucleic Acids Res; 1989 May; 17(10):3981. PubMed ID: 2471958 [No Abstract] [Full Text] [Related]
53. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer]. Morote Robles J; de Torres Mateos JA; Soler-Roselló A Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015 [No Abstract] [Full Text] [Related]
54. Origin of carcinomas causing bladder neck obstruction demonstrated by immunoperoxidase localisation of specific antigens. Al Adnani MS Br J Urol; 1986 Jun; 58(3):283-6. PubMed ID: 3521781 [TBL] [Abstract][Full Text] [Related]
55. General practitioner (GP)'s view on screening for prostate cancer in the Netherlands: the impact of a randomized trial. Schröder FH BJU Int; 2013 Jul; 112(1):4-5. PubMed ID: 23759003 [No Abstract] [Full Text] [Related]
56. Prostate-specific antigen in adenocarcinoma of the prostate. N Engl J Med; 1988 Apr; 318(15):992-3. PubMed ID: 2451131 [No Abstract] [Full Text] [Related]
57. [Immunoperoxidase localization of prostatic acid phosphatase, prostate-specific antigen and gamma seminoprotein in primary and metastatic prostatic carcinoma]. Yamaguchi K; Sumiya H; Fuse H; Ito H; Shimazaki J; Matsuzaki O Nihon Hinyokika Gakkai Zasshi; 1986 May; 77(5):786-90. PubMed ID: 2427766 [No Abstract] [Full Text] [Related]